PROTEOMIC AND METABOLOMIC CHARACTERIZATION OF THE RESPONSE TO INTRAMUSCULAR INFUSION OF AUTOLOGOUS BONE MARROW STEM CELLS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) FOR THE ESTABLISHMENT OF QUANTIFIABLE BIOMARKERS PREDICTIVE OF RESPONSE